Navigation Links
China RuiTai Reports Fiscal Year 2007 Financial Results
Date:4/16/2008

mployees 1,265,898 890,984

Employee security deposit 810,802 677,949

Total Current

Liabilities 55,361,171 48,087,430

Minority Interest 98,053 43,847

Owners' Equity:

Preferred stock, par value $0.001,

10,000,000 shares authorized,

authorized, no shares outstanding -- --

Common stock, par value $0.001,

50,000,000 shares authorized,

22,645,348 shares issued and

outstanding as of December 31,

2006

26,000,000 shares issued and

outstanding as of December 31,

2007 26,000 22,745

Additional paid-in capital 2,366,171 2,369,426

Statutory Reserves 1,042,355 272,979

Retained earnings 5,700,875 1,594,417

Accumulated other comprehensive

income 570,712 80,376

Owners' Equity 9,706,113 4,339,943

Total Liabilities and Owners' Equity $ 65,165,337 $ 52,471,220

CHINA RUITAI INTERNATIONAL HOLDINGS CO., LTD. AND SUBSIDIARIES

F/K/A SHANDONG RUITAI CHEMICAL CO., LTD.

CONSOLIDATED STATEMENTS OF CASH FLOWS

(AUDITED)

For the Year Ended

December 31,

2007 2006

Operating Activities

Net income (loss) $ 4,875,834 $ 3,005,998

Adjustments to reconcile

net income (loss) to


'/>"/>

SOURCE China RuiTai International Holdings Co., Ltd.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine news :

1. Chinas 1-child policy could backfire on its elderly
2. Omnicom Acquires Leading Healthcare Marketing Communications Firm in China
3. Expanding Prevalent Population Will Drive Dramatic Growth for the Asthma Drug Market in China
4. Bridgetech Announces Addition of the Agency for Healthcare Research and Quality as Content Provider in its Development of a Healthcare Web Portal in China
5. China Holdings Appoints Ronald Shon Chairman of Advisory Board to Its Wholly-Owned Subsidiary China Power, Inc.
6. China Bionanometer Industries Corporation Promotes New Cosmetics Product Line in China
7. China Shenghuo Pharmaceutical Holdings, Inc. Begins Full-Scale Launch of 12Ways(R) Chinese Herbal Skin Care Product Line
8. Statement by Mike Leavitt Secretary of Health and Human Services on the United States-China Bilateral Meetings on Food and Drug Safety
9. Supplier Assessments to Help Buyers Identify Reliable China Exporters
10. Study shows lead-based paint problem isnt isolated to China
11. Bracco Announces Initiative to Save Children in China at 2007 Annual Meeting of CGI

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2009)... Innovative medical apparel company launche... San Clemente, Calif. (PRWEB) ...through medical apparel, today announced the launc...Medica 2009, a leading international trade fair fo.... Medelita inaugurates its men,s collection with t...
(Date:11/21/2009)... New Haven Dental Group merges their practi...rd, CT. , (PRWEB) Novembe...d of partners Dr. David Gibson, Dr. Dean Cloutier,...ust merged their growing practice with that of est.... Pickman decided he wanted to retire from dentist...
(Date:11/20/2009)...TON, NJ, Nov. 20 /PRNewswire-FirstCall/ - NUCRYST ...al Meeting of Shareholders will be held on Monday,...to consider approval of two special resolutions. T...orize the sale of all or substantially all of the ...ided for in the asset purchase agreement dated Nov...
(Date:11/20/2009)... Mass., Nov. 20 Following a recall...ny removed from sale Shedd,s Country Crock ® ...,s Country Crock ® Side Dishes DELUXE Four Ch... ,, The following code dates and UPCs are affec...es DELUXE Cheddar Broccoli Rice 21 oz, UPC 0274002...
(Date:11/20/2009)..., Nov. 20 The American ... and Drug Administration (FDA) to establish approp...s. ,, Citing concern about the safety of white...the benefit of professional consultation or examin...application of chemically based tooth whitening or...
Breaking Medicine News(10 mins):Health News:Medelita Introduces Men's Lab Coat Collection 2Health News:Medelita Introduces Men's Lab Coat Collection 3Health News:New Haven Dental Group Expands Their Vision 2Health News:NUCRYST Announces Special Meeting of Shareholders 2Health News:NUCRYST Announces Special Meeting of Shareholders 3Health News:Stop & Shop Alerts Customers to Voluntary Recall by Unilever 2Health News:American Dental Association Petitions FDA to Classify, Regulate Tooth-Whitening Products 2
... Today, the Center for Reproductive Rights issued ...ion provider Dr. George Tiller. Dr. Tiller was mur...ne of the few physicians in the country who provid...ghts represented two-thousand of Dr. Tiller,s pati...
... 2009)Fox Chase Cancer Center investigators report...s safe in metastatic kidney cancer in a phase I tr...sirolimus and bryostatin may be active in patients...ogist and attending physician at Fox Chase will re...
...s efficacy against malignancies that don,t respond...Day News) -- Using a combination of the drugs tems...fe in patients with metastatic kidney cancer, acco...d tumor blood vessel development. The temsirolimus...
...aVita Inc. (NYSE: DVA ), a leading provider of k...ic kidney disease (CKD), today announced the DaVit...the Apple iPhone and iPod Touch has been downloade...of countries where the application has been downlo...
..., May 31 Impac Software, part of the Elekta Group...r of the Year award to Deanna Derdelinghen, Cert...l,s Bennett Cancer Center in Stamford, Connecticut...d extend their contributions to benefit the broade...
...ccuracy of standard PSA test, study shows , ... test greatly reduces false-positive results in pr...tion with a prostate-specific antigen (PSA) test, ... test accurately detected prostate cancer more tha...
Other Medicine News:Health News:Center for Reproductive Rights Deeply Saddened by Murder of Dr. George Tiller 2Health News:Center for Reproductive Rights Deeply Saddened by Murder of Dr. George Tiller 3Health News:Center for Reproductive Rights Deeply Saddened by Murder of Dr. George Tiller 4Health News:Center for Reproductive Rights Deeply Saddened by Murder of Dr. George Tiller 5Health News:Center for Reproductive Rights Deeply Saddened by Murder of Dr. George Tiller 6Health News:Center for Reproductive Rights Deeply Saddened by Murder of Dr. George Tiller 7Health News:Center for Reproductive Rights Deeply Saddened by Murder of Dr. George Tiller 8Health News:Center for Reproductive Rights Deeply Saddened by Murder of Dr. George Tiller 9Health News:Center for Reproductive Rights Deeply Saddened by Murder of Dr. George Tiller 10Health News:Center for Reproductive Rights Deeply Saddened by Murder of Dr. George Tiller 11Health News:2-drug combination appears safe and active in metastatic kidney cancer 2Health News:DaVita's Kidney Calculator iPhone App Downloaded in 24 Countries 2Health News:DaVita's Kidney Calculator iPhone App Downloaded in 24 Countries 3Health News:Impac Software Selects 2009 Cancer Registrar of the Year 2Health News:Impac Software Selects 2009 Cancer Registrar of the Year 3Health News:Gene Test Helps Detect Prostate Cancer 2
(Date:11/19/2009)...-- In response to an ever-increasing number of web...peration Pangea II, involving 24 countries, was co...ation,s International Medical Products Anti-Counte...rs of buying medicines online. ,, The week long... and the seizure of thousands of potentially harmf...
(Date:11/19/2009)...ewswire-FirstCall/ -- Alexza Pharmaceuticals, Inc....te presentation will be webcast live during the 21...Wednesday, December 2, 2009 at 9:00 a.m. Eastern T...w York Palace Hotel in New York and will be presen... ,, To access the live presentation via the Web...
(Date:11/19/2009)...wire/ -- Ligon Discovery, Inc., which uses proprie...drugs against high-value targets, today announced ...cTANK Ventures. The company will use the capital t...l screen over 100 high-value disease protein targe... Partner Christian Bailey joins the board. ,, P...
Breaking Medicine Technology:International Operation Combats Online Supply of Counterfeit and Illegal Medicines 2Alexza Pharmaceuticals to Present at the 21st Annual Piper Jaffray Health Care Conference 2Alexza Pharmaceuticals to Present at the 21st Annual Piper Jaffray Health Care Conference 3Cambridge-based Ligon Discovery Raises $1M in Seed Funding 2Cambridge-based Ligon Discovery Raises $1M in Seed Funding 3Community Oncologists and Patients Stand Up for Cancer Care on Capitol Hill 51047 1Community Oncologists and Patients Stand Up for Cancer Care on Capitol Hill 51047 2Community Oncologists and Patients Stand Up for Cancer Care on Capitol Hill 51047 3Community Oncologists and Patients Stand Up for Cancer Care on Capitol Hill 51047 4Community Oncologists and Patients Stand Up for Cancer Care on Capitol Hill 51047 5Hip Arthroscopy Procedures to Soar Through 2013 51045 1Hip Arthroscopy Procedures to Soar Through 2013 51045 2DOR BioPharma Announces Issuance of European Patent for its LPM 28TM 29 Oral Drug Delivery Technology 12934 1DOR BioPharma Announces Issuance of European Patent for its LPM 28TM 29 Oral Drug Delivery Technology 12934 2DOR BioPharma Announces Issuance of European Patent for its LPM 28TM 29 Oral Drug Delivery Technology 12934 3DOR BioPharma Announces Issuance of European Patent for its LPM 28TM 29 Oral Drug Delivery Technology 12934 4DOR BioPharma Announces Issuance of European Patent for its LPM 28TM 29 Oral Drug Delivery Technology 12934 5
... Phase 1/2 Trial of TRU-016, Trubion,s Proprietary...I-087 for RA Expands Trubion,s Family of Customize...t Candidates, SEATTLE, March 27 Trubion Pharmace... it has initiated a Phase 1/2,clinical trial of TR...r,ImmunoPharmaceutical (SMIP(TM)) drug candidate, ...
...ng Therapeutic Value of Cord Blood Stem Cells, OL...bilical cord blood are showing early potential in ... from a new preclinical study,published in the Mar...conducted by researchers from the University of So...ound that targeted immune suppression using stem,c...
Other Medicine Technology:Trubion Initiates Phase 1/2 Study of TRU-016 in CLL, Announces Next-Generation Product Candidate for RA and Provides Product Pipeline Update 2Trubion Initiates Phase 1/2 Study of TRU-016 in CLL, Announces Next-Generation Product Candidate for RA and Provides Product Pipeline Update 3Trubion Initiates Phase 1/2 Study of TRU-016 in CLL, Announces Next-Generation Product Candidate for RA and Provides Product Pipeline Update 4Trubion Initiates Phase 1/2 Study of TRU-016 in CLL, Announces Next-Generation Product Candidate for RA and Provides Product Pipeline Update 5Early Research Suggests Umbilical Cord Blood Cell Therapy May Reduce Progression of Alzheimer's Disease 2Early Research Suggests Umbilical Cord Blood Cell Therapy May Reduce Progression of Alzheimer's Disease 3Early Research Suggests Umbilical Cord Blood Cell Therapy May Reduce Progression of Alzheimer's Disease 4Early Research Suggests Umbilical Cord Blood Cell Therapy May Reduce Progression of Alzheimer's Disease 5
... national reference laboratory and a worldwide lea...ent. ARUP offers an extensive test menu of highly ...natomic pathology. Owned by the University of Utah...f of the nation's university teaching hospitals an...
... national reference laboratory and a worldwide lea...ent. ARUP offers an extensive test menu of highly ...natomic pathology. Owned by the University of Utah...f of the nation's university teaching hospitals an...
... national reference laboratory and a worldwide lea...ent. ARUP offers an extensive test menu of highly ...natomic pathology. Owned by the University of Utah...f of the nation's university teaching hospitals an...
... national reference laboratory and a worldwide lea...ent. ARUP offers an extensive test menu of highly ...natomic pathology. Owned by the University of Utah...f of the nation's university teaching hospitals an...
Medicine Products: